Condition

Elevated PSA

ClinicalTrials.gov condition label

Clinical trials7

Recruiting2

Common interventions10

Lead sponsors shown7

Clinical trials

7 shown

PSMA PET Combined With MRI for the Detection of PCaNCT07052214 · 2025-08-18

Upright MRI for Prostate Cancer ScreeningNCT03474913 · 2018-10-01

Marker Driven Selection of Patients for Prostate Biopsy and ManagementNCT04240327 · 2020-06-29

ACTIVE_NOT_RECRUITING

A Prospective, Randomized Trial Comparing Office-based MR-guided Prostate Biopsy ApproachesNCT03632655 · 2017-12-23

Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSANCT03234556 · 2017-09-25

ACTIVE_NOT_RECRUITING

Prospective Assessment of Image Registration for the Diagnosis of Prostate CancerNCT02425228 · 2014-12-04

Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative BiopsyNCT00242060 · 2002-11-01

Common interventions

68Ga-PSMA-11DRUG1 Biopsy of ProstatePROCEDURE1 Laboratory Biomarker AnalysisOTHER1 Magnetic Resonance ImagingDIAGNOSTIC_TEST1 MRIPROCEDURE1 MRI Ultrasound Fusion Guided BiopsyDIAGNOSTIC_TEST1 prostate biopsyPROCEDURE1 Standard MRIDEVICE1 Targeted biopsyDEVICE1 Upright MRIDEVICE1

Leading sponsors

Icahn School of Medicine at Mount Sinai1 Jonsson Comprehensive Cancer Center1 Telix Pharmaceuticals (Innovations) Pty Limited1 University Health Network, Toronto1 University of Miami1 University of Southern California1 Weill Medical College of Cornell University1

Trial status mix

ACTIVE_NOT_RECRUITING2

COMPLETED2

RECRUITING2

TERMINATED1

Phase mix

NA3

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.